Pharmacokinetics/pharmacodynamics of echinocandins (Q34551922)

3 August 2017

1 reference

title

Pharmacokinetics/pharmacodynamics of echinocandins (English)

1 reference

3 August 2017

1 reference

1 reference

U Theuretzbacher

1

1 reference

3 August 2017

publication date

14 October 2004

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

3 August 2017

published in

1 reference

3 August 2017

volume

23

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

805-812

1 reference

Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans

3 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007/S10096-004-1228-Z

Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007/S10096-004-1228-Z

Uptake of itraconazole by alveolar macrophages

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007/S10096-004-1228-Z

Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen

21 January 2018

1 reference

12 December 2020

Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling

1 reference

12 December 2020

In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi

1 reference

12 December 2020

Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus

1 reference

12 December 2020

Ultrastructure and possible processes involved in the invasion of host epithelial cells by Candida albicans in vaginal candidosis

1 reference

12 December 2020

Antifungal susceptibility testing: practical aspects and current challenges

1 reference

12 December 2020

Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections

1 reference

12 December 2020

Evaluation of voriconazole pharmacodynamics using time-kill methodology

1 reference

12 December 2020

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

1 reference

12 December 2020

Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.

1 reference

12 December 2020

The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro

1 reference

12 December 2020

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

1 reference

12 December 2020

Animal model pharmacokinetics and pharmacodynamics: a critical review

1 reference

12 December 2020

Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate

1 reference

12 December 2020

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

1 reference

12 December 2020

Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits

1 reference

12 December 2020

Clinical pharmacodynamics of antifungals.

1 reference

12 December 2020

Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits

1 reference

12 December 2020

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans

1 reference

12 December 2020

Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations

1 reference

12 December 2020

In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model

1 reference

12 December 2020

Echinocandins: a new class of antifungal

1 reference

12 December 2020

Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis

1 reference

12 December 2020

Has antifungal susceptibility testing come of age?

1 reference

12 December 2020

Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans

1 reference

12 December 2020

Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.

1 reference

12 December 2020

Influence of human serum on antifungal pharmacodynamics with Candida albicans

1 reference

12 December 2020

Is there a correlation between serum antifungal drug concentration and clinical outcome?

1 reference

12 December 2020

In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model

1 reference

12 December 2020

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine

1 reference

12 December 2020

Interactions of Aspergillus fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity

1 reference

12 December 2020

Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice

1 reference

12 December 2020

Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma

1 reference

12 December 2020

Histoplasma capsulatum modulates the acidification of phagolysosomes

1 reference

12 December 2020

Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis

1 reference

12 December 2020

Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages

1 reference

12 December 2020

Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate

1 reference

12 December 2020

Influence of serum protein binding on the in vitro activity of anti-fungal agents

1 reference

12 December 2020

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

1 reference

12 December 2020

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

1 reference

12 December 2020

In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi

1 reference

12 December 2020

In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies

1 reference

12 December 2020

10.1007/S10096-004-1228-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1011526203

0 references

1 reference